Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM

过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用

基本信息

  • 批准号:
    7804877
  • 负责人:
  • 金额:
    $ 0.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Type 2 diabetes mellitus (T2DM) is getting epidemic threatening millions of people and its increase is tightly related with the rapid increase of obesity throughout the world. Insulin resistance may proceed decades before the onset of diabetes and it is common in obese individuals. My long term goal in research is finding primary cause(s) of insulin resistance and elucidating the interactions between glucose and lipid metabolism in T2DM, which are essential for strategy development to prevent the onset of diabetes and to fine a cure or better treatments for the disease. A key clinical observation for diagnosis of diabetes is fasting hyperglycemia. Hepatic glucose overproduction contributes fasting hyperglycemia, but controversial data have been reported about the roles of glycogenolysis and gluconeogenesis in T2DM. Recently I found that preserved liver glycogen in fasting resulted in excess glycogenolysis, and subsequently contributed fasting hyperglycemia in rodent models for obesity-associated T2DM. This observation could be important in understanding the failure of hepatic glucose autoregulation in obese T2DM patients because increased fasting hepatic glycogen was reported in obese humans and T2DM patients. Excess liver glycogen in fasting could be critical in fasting hyperglycemia in those individuals because endogenous glucose production is sensitive to the amount of hepatic glycogen available for hydrolysis. In this proposal, liver metabolic changes in obesity and in obesity-associated T2DM will be evaluated in the connection with systemic metabolic fluxes of whole animals. A short-term high-fat diet induced hepatic insulin resistance and the interaction between lipid and carbohydrate metabolism in obesity-associated T2DM will be evaluated focusing hepatic glycogen. It will be determined whether inhibition of glycogenolysis alters fasting hyperglycemia in rodent models of obesity-associated T2DM. The Advanced Imaging Research Center has pioneered in method development to evaluate comprehensive metabolic fluxes in vivo and to study intermediary metabolism using simultaneous administration of stable isotope tracers. The technologies with high field nuclear magnetic resonance (NMR) spectroscopy will be adapted in performing proposed research projects.
描述(由申请人提供): 2型糖尿病(Type 2 Diabetes Mellitus,T2DM)是一种流行性疾病,它的发病与肥胖的迅速增加密切相关。胰岛素抵抗可能在糖尿病发病前几十年就已发生,在肥胖者中很常见。我的长期研究目标是找到胰岛素抵抗的主要原因,并阐明T2DM中葡萄糖和脂质代谢之间的相互作用,这对于预防糖尿病发作和找到治愈或更好治疗该疾病的策略至关重要。诊断糖尿病的关键临床观察是空腹高血糖。肝脏葡萄糖过度生成导致空腹高血糖,但关于糖原分解和糖原异生在T2DM中的作用,已有争议性数据报道。最近,我发现在肥胖相关T2DM的啮齿动物模型中,禁食时保留的肝糖原导致过度的糖原分解,随后导致空腹高血糖。这一观察结果对于了解肥胖T2DM患者中的肝葡萄糖自动调节失败可能很重要,因为在肥胖人类和T2DM患者中报告了空腹肝糖原增加。在这些个体中,空腹时过多的肝糖原可能是空腹高血糖的关键,因为内源性葡萄糖的产生对可用于水解的肝糖原的量敏感。在本提案中,将结合整个动物的全身代谢通量评价肥胖和肥胖相关T2DM中的肝脏代谢变化。将评价短期高脂饮食诱导的肝脏胰岛素抵抗以及肥胖相关T2DM中脂质和碳水化合物代谢之间的相互作用,重点是肝糖原。将确定糖原分解抑制是否改变肥胖相关T2DM啮齿动物模型中的空腹高血糖。先进的成像研究中心已率先在方法开发,以评估全面的代谢通量在体内,并研究中间代谢,同时管理的稳定同位素示踪剂。高场核磁共振(NMR)光谱技术将适用于执行拟议的研究项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EUNSOOK JIN其他文献

EUNSOOK JIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EUNSOOK JIN', 18)}}的其他基金

13C asymmetry in blood glucose as a marker for oxidative stress in liver
血糖中的 13C 不对称性作为肝脏氧化应激的标志
  • 批准号:
    8891416
  • 财政年份:
    2014
  • 资助金额:
    $ 0.11万
  • 项目类别:
13C asymmetry in blood glucose as a marker for oxidative stress in liver
血糖中的 13C 不对称性作为肝脏氧化应激的标志
  • 批准号:
    9288174
  • 财政年份:
    2014
  • 资助金额:
    $ 0.11万
  • 项目类别:
MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
2 型糖尿病中葡萄糖产生过多的机制
  • 批准号:
    8363906
  • 财政年份:
    2011
  • 资助金额:
    $ 0.11万
  • 项目类别:
MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
2 型糖尿病中葡萄糖产生过多的机制
  • 批准号:
    8171657
  • 财政年份:
    2010
  • 资助金额:
    $ 0.11万
  • 项目类别:
MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
2 型糖尿病中葡萄糖产生过多的机制
  • 批准号:
    7956975
  • 财政年份:
    2009
  • 资助金额:
    $ 0.11万
  • 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
  • 批准号:
    7766217
  • 财政年份:
    2008
  • 资助金额:
    $ 0.11万
  • 项目类别:
EXCESS GLUCOSE PRODUCTION: GLYCOGEN OR TCA-CYCLE GLUCONEOGENESIS?
葡萄糖产生过多:糖原或 TCA 循环糖异生?
  • 批准号:
    7724125
  • 财政年份:
    2008
  • 资助金额:
    $ 0.11万
  • 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
  • 批准号:
    7470349
  • 财政年份:
    2008
  • 资助金额:
    $ 0.11万
  • 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
  • 批准号:
    7590345
  • 财政年份:
    2008
  • 资助金额:
    $ 0.11万
  • 项目类别:
EXCESS GLUCOSE PRODUCTION: GLYCOGEN OR TCA-CYCLE GLUCONEOGENESIS?
葡萄糖产生过多:糖原或 TCA 循环糖异生?
  • 批准号:
    7600859
  • 财政年份:
    2007
  • 资助金额:
    $ 0.11万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 0.11万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 0.11万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 0.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 0.11万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 0.11万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 0.11万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 0.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 0.11万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 0.11万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 0.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了